Facial Paralysis: Clinical Trials

3 trials for Facial Paralysis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Terminated 1

Follow Facial Paralysis: new trials by email Literature Review of Facial Paralysis trials Research Report on Facial Paralysis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Cortisone Treatment in Children With Acute Facial Nerve Palsy
Prednisolone, Placebo Oral Tablet - Facial Palsy, Facial Nerve Diseases
Phase 4CompletedDalarna County Council, Sweden3432019-05-032026-09-02
Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty
injection of 1% lidocaine, 2mL for facial nerve block - Facial Paresis
Phase 4TerminatedUniversity Hospital, Caen102013-04-012016-05-25
Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis
OnabotulinumtoxinA Injectable Product, AbobotulinumtoxinA Injectable Product, Incobotulinumtoxin A Injectable Product - Facial Nerve Injuries, Facial Paresis Associated With Facial Nerve Dysfunction
Phase 4CompletedUniversity of Utah712012-07-012017-07-31

Narrower conditions

Bell Palsy (1)  ·  Facial Asymmetry (1)  ·  Facial Nerve Diseases (1)  ·  Facial Nerve Injuries (1)  ·  Synkinesis (1)

Broader conditions

Mouth Diseases (3)  ·  Nervous System Diseases (3)  ·  Neurologic Manifestations (3)  ·  Paralysis (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Stomatognathic Diseases (3)  ·  Cranial Nerve Diseases (2)  ·  Cranial Nerve Injuries (1)  ·  Craniocerebral Trauma (1)  ·  DNA Virus Infections (1)  ·  Dyskinesias (1)  ·  Facial Nerve Diseases (1)  ·  Herpesviridae Infections (1)  ·  Infections (1)

Interventions

Botulinum Toxins, Type A (1)  ·  Lidocaine (1)  ·  Prednisolone (1)  ·  abobotulinumtoxinA (1)  ·  incobotulinumtoxinA (1)

Sponsors

Dalarna County Council, Sweden (1)  ·  University Hospital, Caen (1)  ·  University of Utah (1)

Countries

France (1)  ·  Sweden (1)

Top investigators

Barbro Hedin Skogman, MD, PhD (1)  ·  Preston D Ward, MD (1)

Results publications

PMID 28973094, PMID 33947355

NIH funding

2017 (1)